Coronavirus Disease (COVID-19) and Peritoneal Malignancies
- PMID: 33488021
- PMCID: PMC7811347
- DOI: 10.1007/s13193-020-01270-9
Coronavirus Disease (COVID-19) and Peritoneal Malignancies
Keywords: COVID-19; Cancer; Cytoreductive surgery; Hyperthermic chemotherapy; Pandemic; Peritoneal malignancies.
Conflict of interest statement
Conflict of InterestThe authors declare that they do not have conflict of interest.
References
-
- Glehen O, Kepenekian V, Bouché O, Gladieff L, Honore C, RENAPE-BIG-RENAPE Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. J Visc Surg. 2020;157(3S1):S25–S31. doi: 10.1016/j.jviscsurg.2020.04.013. - DOI - PMC - PubMed
-
- LYW L, Cazier JB, Starkey T, Turnbull CD, UK Coronavirus Cancer Monitoring Project Team. Kerr R, Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926. doi: 10.1016/S0140-6736(20)31173-9. - DOI - PMC - PubMed
-
- COVIDSurg Collaborative Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study [published online ahead of print, 2020 May 29] [published correction appears in Lancet. 2020 Jun 9] Lancet. 2020;S0140–6736(20):31182-X. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources